secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2023-11-24T23:59:59+00:00
Accession:  0001824293-23-000175
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio receives Nasdaq delisting notice for failing stockholders' equity requirement
--------------------------------------------------------------------------------

- Notice received Nov 22, 2023 for non-compliance with Nasdaq Listing Rule 5550(b)(1) requiring minimum $2.5M stockholders' equity.
- Stockholders' equity fell below $2.5M as of September 30, 2023 based on Q3 10-Q.
- Company must submit a compliance plan by January 6, 2024 to avoid potential delisting.
- If plan accepted, Nasdaq may grant up to 180 calendar days extension to regain compliance.
- No immediate effect on trading but risk of delisting if compliance plan is rejected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429323000175/0001824293-23-000175-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429323000175/val-20231122.htm
  HTML page:      https://secwatch.observer/filing/0001824293-23-000175

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer